Ravi Kumar Paluri, MD, MPH
- Associate Professor, Hematology and Oncology

Ravi Kumar Paluri, MD, MPH
- Education
- MB, BS, Kakatiya Medical College - India, 2007
- MPH, University of Alabama - Birmingham, 2009
- Residency
- Internal Medicine, University of Alabama at Birmingham, 2012
- Fellowship
- Hematology / Oncology, University of Alabama at Birmingham, 2015
- Board Certifications
- American Board of Internal Medicine, Hematology
- American Board of Internal Medicine, Internal Medicine
- American Board of Internal Medicine, Medical Oncology
- Positions
- Associate Professor, Hematology and Oncology
- Departments and Affiliations
- Hematology and Oncology
- Comprehensive Cancer Center
Research
- CAR T Cell Therapy in Pancreaticobiliary Cancers: a Focused Review of Clinical Data. Anwar MY, Williams GR, Paluri RK. J Gastrointest Cancer. 2021 Mar; 52(1):1-10.
- Association between Primary Perioperative CEA Ratio, Tumor Site, and Overall Survival in Patients with Colorectal Cancer. Odeny TA, Farha N, Hildebrandand H, Allen J, Vazquez W, Martinez M, Paluri RK, Kasi A. J Clin Med. 2020 Nov; 9(12)
- Depression among older adults with gastrointestinal malignancies. Godby RC, Dai C, Al-Obaidi M, Giri S, Young-Smith C, Kenzik K, McDonald AM, Paluri RK, Gbolahan OB, Bhatia S, Williams GR. J Geriatr Oncol. 2021 May; 12(4):599-604.
- Financial Distress Among Older Adults With Cancer. Giri S, Clark D, Al-Obaidi M, Varnado W, Kumar S, Paluri R, Gbolahan O, Bhatia S, Williams GR. JCO Oncol Pract. 2020 Oct; :OP2000601.
- Survival Outcomes of Pancreatic Intraepithelial Neoplasm (PanIN) versus Intraductal Papillary Mucinous Neoplasm (IPMN) Associated Pancreatic Adenocarcinoma. McGinnis T, Bantis LE, Madan R, Dandawate P, Kumer S, Schmitt T, Paluri RK, Kasi A. J Clin Med. 2020 Sep; 9(10)
- Study of the Drug Minnelide Given Alone or in Combination with Protein-Bound Paclitaxel in Patients with Advanced Solid Tumors
- Study on the Effectiveness of the Drug GP-2250 in Combination with the Drug Gemcitabine in Individuals with Advanced or Metastatic Pancreatic Adenocarcinoma
- Adding the TheraBionic Device to Treatment for Advanced Pancreatic Cancer